(Q420296)

Statements

instance of

type of chemical entity

0 references

subclass of

chemical compound

0 references

has use

medication

1 reference

title

Cetuximab (English)

stated in

DrugBank

language of work or name

English

publication date

17 November 2015

DrugBank ID

00002

image of molecular model or crystal lattice model

Cetuximab.png
1,020 × 623; 136 KB

depicts

ribbon diagram

0 references

active ingredient in

Erbitux

1 reference

European Medicines Agency product number

EMEA/H/C/000558

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000558/human_med_000769.jsp

retrieved

22 March 2017

World Health Organisation international non-proprietary name

cetuximab (English)

1 reference

stated in

ChEMBL

ChEMBL ID

CHEMBL1201577

language of work or name

English

title

Cetuximab (English)

retrieved

19 January 2016

medical condition treated

colon cancer

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

tongue squamous cell carcinoma

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

cutaneous squamous-cell carcinoma

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

head and neck squamous cell carcinoma

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

laryngeal cancer

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

colon adenocarcinoma

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

gum cancer

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

hypopharynx cancer

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

non-small-cell lung carcinoma

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

rectum cancer

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

tongue cancer

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

rectum adenocarcinoma

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

tonsil cancer

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

oropharynx cancer

1 reference

stated in

Drug Indications Extracted from FAERS

retrieved

2 October 2018

route of administration

intravenous infusion and defusion

1 reference

imported from Wikimedia project

Russian Wikipedia

Wikimedia import URL

https://ru.wikipedia.org/?oldid=100714796

legal status (medicine)

boxed warning

1 reference

reference URL

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

title

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

Australian pregnancy category D

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

stated in

LiverTox

retrieved

8 April 2021

reference URL

https://www.ncbi.nlm.nih.gov/books/n/livertox/Cetuximab

last update

3 October 2017

has characteristic

biopharmaceutical

1 reference

title

Cetuximab (English)

stated in

DrugBank

language of work or name

English

publication date

17 November 2015

DrugBank ID

00002

subject has role

immunological antineoplastic agent

1 reference

stated in

Medical Subject Headings

MeSH descriptor ID

D000068818

retrieved

15 March 2018

monoclonal antibody

1 reference

stated in

DrugBank

DrugBank ID

00002

language of work or name

English

title

Cetuximab (English)

publication date

17 November 2015

Commons category

Cetuximab

0 references

Identifiers